Dr. Brad David Simons, MD, PA, PhD

Dr. Simons practices at Advanced Eye Care in Orlando, Florida.

Dr. Simons' NPI, 1801874896, was assigned on January 9, 2006. Dr. Simons graduated from Warren Alpert Medical School of Brown University in 1992. Dr. Simons holds Florida license ME76183.

Dr. Simons' primary practice is Advanced Eye Care, at 1911 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 893-8200.

Dr. Simons' primary practice is Advanced Eye Care in Orlando, Florida. Dmand AI also links Dr. Simons to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simons practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Simons' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Simons is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Simons' licenses on file in 3 states: Florida, Michigan and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Simons treats.

CMS data shows 3,654 Medicare services from Dr. Simons across 12 procedure codes in 2024, for 322 Medicare patients. Medicare paid $215,138 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Dr. Simons in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Simons' median patient age at 43, with 57% women.

In 2024, Dr. Simons wrote 3,350 Medicare Part D claims for 622 patients. 66% of them were for generic drugs. CMS names the drug for 3,260 of them, across 26 drugs with 11 or more claims each, at $184,064 in total drug cost. In 2023, CMS named 3,028 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Simons for performance year 2024, reported individually. Dr. Simons accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Simons in 2011. 2011 was the busiest year, with 2. The most frequent topics are Cataract Extraction, Antihypertensive Agents and Cataract. Dr. Simons has published most often in J Pediatr Ophthalmol Strabismus. Dr. Simons' most frequent co-authors are Barbara M. Wirostko, MD and Harry W. Flynn, MD.

CMS Open Payments shows 19 general payments to Dr. Simons from 10 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 95% of the total. Beaver-Visitec International, Inc. paid the most, $127.

Dr. Simons graduated from Warren Alpert Medical School of Brown University in 1992.

Dr. Simons is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.